1998 related articles for article (PubMed ID: 29873596)
41. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.
Kobori H; Nangaku M; Navar LG; Nishiyama A
Pharmacol Rev; 2007 Sep; 59(3):251-87. PubMed ID: 17878513
[TBL] [Abstract][Full Text] [Related]
42. Counter-regulatory effects played by the ACE - Ang II - AT1 and ACE2 - Ang-(1-7) - Mas axes on the reactive oxygen species-mediated control of vascular function: perspectives to pharmacological approaches in controlling vascular complications.
Pernomian L; Pernomian L; Baraldi Araújo Restini C
Vasa; 2014 Nov; 43(6):404-14. PubMed ID: 25339158
[TBL] [Abstract][Full Text] [Related]
43. Signaling mechanisms of angiotensin II in regulating vascular senescence.
Min LJ; Mogi M; Iwai M; Horiuchi M
Ageing Res Rev; 2009 Apr; 8(2):113-21. PubMed ID: 19162241
[TBL] [Abstract][Full Text] [Related]
44. From converting enzyme inhibition to angiotensin II receptor blockade: new insight on angiotensin II receptor subtypes in the kidney.
Wolf G; Neilson EG
Exp Nephrol; 1996; 4 Suppl 1():8-19. PubMed ID: 9001892
[TBL] [Abstract][Full Text] [Related]
45. Role of Mas receptor antagonist (A779) in renal hemodynamics in condition of blocked angiotensin II receptors in rats.
Mansoori A; Oryan S; Nematbakhsh M
Physiol Int; 2016 Mar; 103(1):13-20. PubMed ID: 27030624
[TBL] [Abstract][Full Text] [Related]
46. Intrarenal suppression of angiotensin II type 1 receptor binding molecule in angiotensin II-infused mice.
Wakui H; Tamura K; Matsuda M; Bai Y; Dejima T; Shigenaga A; Masuda S; Azuma K; Maeda A; Hirose T; Ishigami T; Toya Y; Yabana M; Minamisawa S; Umemura S
Am J Physiol Renal Physiol; 2010 Nov; 299(5):F991-F1003. PubMed ID: 20739392
[TBL] [Abstract][Full Text] [Related]
47. Angiotensin-(1-7): beyond the cardio-renal actions.
Passos-Silva DG; Verano-Braga T; Santos RA
Clin Sci (Lond); 2013 Apr; 124(7):443-56. PubMed ID: 23249272
[TBL] [Abstract][Full Text] [Related]
48. Novel roles of intracrine angiotensin II and signalling mechanisms in kidney cells.
Zhuo JL; Li XC
J Renin Angiotensin Aldosterone Syst; 2007 Mar; 8(1):23-33. PubMed ID: 17487823
[TBL] [Abstract][Full Text] [Related]
49. Luminal ANG II is internalized as a complex with AT
Ferrão FM; Cardoso LHD; Drummond HA; Li XC; Zhuo JL; Gomes DS; Lara LS; Vieyra A; Lowe J
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F440-F449. PubMed ID: 28468964
[TBL] [Abstract][Full Text] [Related]
50. Angiotensin receptor subtypes of the kidney cortex.
Douglas JG
Am J Physiol; 1987 Jul; 253(1 Pt 2):F1-7. PubMed ID: 3300368
[TBL] [Abstract][Full Text] [Related]
51. Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy.
Chen J; Chen JK; Neilson EG; Harris RC
J Am Soc Nephrol; 2006 Jun; 17(6):1615-23. PubMed ID: 16641152
[TBL] [Abstract][Full Text] [Related]
52. The pathophysiological role of angiotensin receptor-binding protein in hypertension and kidney diseases: Oshima Award Address 2019.
Wakui H
Clin Exp Nephrol; 2020 Apr; 24(4):289-294. PubMed ID: 32112267
[TBL] [Abstract][Full Text] [Related]
53. AT1 receptor signaling pathways in the cardiovascular system.
Kawai T; Forrester SJ; O'Brien S; Baggett A; Rizzo V; Eguchi S
Pharmacol Res; 2017 Nov; 125(Pt A):4-13. PubMed ID: 28527699
[TBL] [Abstract][Full Text] [Related]
54. Novel mechanisms of G-protein-coupled receptors functions: AT
Tóth AD; Turu G; Hunyady L; Balla A
Best Pract Res Clin Endocrinol Metab; 2018 Apr; 32(2):69-82. PubMed ID: 29678287
[TBL] [Abstract][Full Text] [Related]
55. [Angiotensin II receptor blockers: current status and future prospects].
Corvol P; Plouin PF
Drugs; 2002; 62 Spec No 1():53-64. PubMed ID: 12036389
[TBL] [Abstract][Full Text] [Related]
56. Angiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiological implications.
Bottari SP; de Gasparo M; Steckelings UM; Levens NR
Front Neuroendocrinol; 1993 Apr; 14(2):123-71. PubMed ID: 8486206
[TBL] [Abstract][Full Text] [Related]
57. Angiotensin II Type 1 Receptor-Associated Protein Regulates Kidney Aging and Lifespan Independent of Angiotensin.
Uneda K; Wakui H; Maeda A; Azushima K; Kobayashi R; Haku S; Ohki K; Haruhara K; Kinguchi S; Matsuda M; Ohsawa M; Minegishi S; Ishigami T; Toya Y; Atobe Y; Yamashita A; Umemura S; Tamura K
J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28751545
[TBL] [Abstract][Full Text] [Related]
58. Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling.
Banday AA; Lokhandwala MF
Hypertension; 2008 Dec; 52(6):1099-105. PubMed ID: 18955661
[TBL] [Abstract][Full Text] [Related]
59. Adenovirus-mediated overexpression and stimulation of the human angiotensin II type 2 receptor in porcine cardiac fibroblasts does not modulate proliferation, collagen I mRNA expression and ERK1/ERK2 activity, but inhibits protein tyrosine phosphatases.
Warnecke C; Kaup D; Marienfeld U; Poller W; Yankah C; Gräfe M; Fleck E; Regitz-Zagrosek V
J Mol Med (Berl); 2001 Sep; 79(9):510-21. PubMed ID: 11692164
[TBL] [Abstract][Full Text] [Related]
60. Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB.
Li D; Saldeen T; Romeo F; Mehta JL
Circulation; 2000 Oct; 102(16):1970-6. PubMed ID: 11034947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
